← All trials
NCT07180108
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 12, 2025
- Primary completion
- Jun 30, 2028
- Completion date
- Aug 31, 2028
- First posted
- Sep 18, 2025
- Last posted
- Sep 18, 2025
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Johns Hopkins UniversityLead sponsor
- Johns Hopkins UniversityOfficial
- Steven & Alexandra Cohen Children's Medical Center, New YorkCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.